TARGETRIN THERAPEUTICS
Targetrin will develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP manufacturing capabilities of Cyclolab and EpiPharma’s proteomimetic peptide chemistry platform.
TARGETRIN THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Budapest, Budapest, Hungary
Country:
Hungary
Status:
Active
Similar Organizations
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Phenex Pharmaceuticals
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.
More informations about "Targetrin Therapeutics"
Targetrin Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, acquisitions, investors, and executives for Targetrin Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin
Nov 1, 2021 Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs January 11, 2021 …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin ...
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint …See details»
Targetrin Therapeutics - Crunchbase
Targetrin Therapeutics, Phenex Pharmaceuticals, and NephroDI Therapeutics operate in the pharmaceutical and drug development sector. Targetrin Therapeutics focuses on novel drug …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin ...
Jan 11, 2021 Targetrin will develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP manufacturing capabilities of Cyclolab and …See details»
Cyclolab, EpiPharma form Joint Venture Company Targetrin …
Jan 14, 2021 Targetrin will develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP manufacturing capabilities of Cyclolab and …See details»
Target Therapeutics, Inc. Company Profile | Marlborough, MA ...
Find company research, competitor information, contact details & financial data for Target Therapeutics, Inc. of Marlborough, MA. Get the latest business insights from Dun & Bradstreet.See details»
Targetrin Therapeutics LLC: Drug pipelines, Patents, Clinical trials ...
Jun 17, 2023 Explore Targetrin Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, .See details»
Targetrin Therapeutics:Company Profile & Technical …
Targetrin Therapeutics is a company that provides Cyclodextrin, Drug candidate and more. Targetrin Therapeutics is headquartered in Hungary Budapest. Related Topics …See details»
Cyclodextrin News
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint venture.See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin ...
Jan 11, 2021 Cyclolab and EpiPharma announced that the companies have signed an agreement to form a joint venture specialty pharmaceutical company to develop and …See details»
Research programme: conjugated cyclodextrin-peptide …
Conjugated cyclodextrin-peptide therapeutics are being developed by Targetrin (JV of Cyclolab and EpiPharma) for the treatment of CNS and pulmonary diseases.See details»
Therapeutic Targeting of BET proteins in Sarcoma
2 days ago Abstract. Bromodomain and extraterminal domain (BET) protein family are epigenetic readers that regulate gene transcription, cell cycle progression, and DNA damage …See details»
Target Therapeutics - Crunchbase Company Profile & Funding
Target Therapeutics develops disposable medical devices for use in minimally-invasive procedures that are used to treat vascular diseases.See details»
Structure Therapeutics Announces Selection of Lead Oral Small …
About Structure Therapeutics Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small …See details»
Calcitonin gene-related peptide-targeted therapy in migraine: …
6 days ago Almost 40 years ago, the discovery of the vasoactive neuropeptide calcitonin gene-related peptide (CGRP) and its role in migraine pathophysiology ushered in a new era in …See details»
New study results reinforce Tagrisso as the backbone therapy for …
3 days ago New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy …See details»
Transforming oncology: The rise of targeted radiopharmaceuticals
4 days ago The expanding pipeline of targeted radiopharmaceuticals has sparked a flurry of business development and licensing activities among major pharmaceutical companies. Over …See details»
Amylin targeting therapeutic - Orion Biotechnology Canada
Jan 7, 2025 Amylin targeting therapeutic is being developed by Orion Biotechnology Canada for the treatment of metabolic disorders. Company is using PROcisionXTM DiscoverySee details»
Targeting HINT1 to improve synaptic plasticity: toward loganin
3 days ago In this study, we reported HINT1, a potential therapeutic target for depression, and that loganin might target HINT1 to improve depressive-like behaviors.See details»